Inflammation, insulin resistance, and diabetes-mendelian randomization using CRP haplotypes points upstream

被引:133
作者
Brunner, Eric J. [1 ]
Kivimaeki, Mika [1 ]
Witte, Daniel R. [1 ]
Lawlor, Debbie A. [2 ]
Smith, George Davey [2 ]
Cooper, Jackie A. [3 ]
Miller, Michelle [4 ]
Lowe, Gordon D. O. [5 ]
Rumley, Ann [5 ]
Casas, Juan P. [6 ]
Shah, Tina [7 ]
Humphries, Steve E. [3 ]
Hingorani, Aroon D. [1 ]
Marmot, Michael G. [1 ]
Timpson, Nicholas J. [2 ]
Kumari, Meena [1 ]
机构
[1] Royal Free & Univ Coll Med Sch, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England
[2] Univ Bristol, Ctr Causal Analyses Translat Epidemiol, MRC, Bristol, Avon, England
[3] Royal Free & Univ Coll Med Sch, British Heart Fdn Labs, Ctr Cardiovasc Genet, London WC1E 6BT, England
[4] Warwick Med Sch, Clin Sci Res Inst, Coventry, W Midlands, England
[5] Univ Glasgow, Royal Infirm, Div Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
[6] London Sch Hyg & Trop Med, Noncommunicable Dis Epidemiol Unit, London WC1, England
[7] UCL, Ctr Clin Pharmacol, Div Med, London, England
来源
PLOS MEDICINE | 2008年 / 5卷 / 08期
基金
英国医学研究理事会; 英国惠康基金;
关键词
D O I
10.1371/journal.pmed.0050155
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Raised C-reactive protein (CRP) is a risk factor for type 2 diabetes. According to the Mendelian randomization method, the association is likely to be causal if genetic variants that affect CRP level are associated with markers of diabetes development and diabetes. Our objective was to examine the nature of the association between CRP phenotype and diabetes development using CRP haplotypes as instrumental variables. Methods and Findings We genotyped three tagging SNPs (CRP + 2302G > A; CRP + 1444T > C; CRP + 4899T > G) in the CRP gene and measured serum CRP in 5,274 men and women at mean ages 49 and 61 y (Whitehall II Study). Homeostasis model assessment-insulin resistance (HOMA-IR) and hemoglobin A1c (HbA1c) were measured at age 61 y. Diabetes was ascertained by glucose tolerance test and self-report. Common major haplotypes were strongly associated with serum CRP levels, but unrelated to obesity, blood pressure, and socioeconomic position, which may confound the association between CRP and diabetes risk. Serum CRP was associated with these potential confounding factors. After adjustment for age and sex, baseline serum CRP was associated with incident diabetes (hazard ratio = 1.39 [95% confidence interval 1.29-1.51], HOMA-IR, and HbA1c, but the associations were considerably attenuated on adjustment for potential confounding factors. In contrast, CRP haplotypes were not associated with HOMA-IR or HbA1c (p=0.52-0.92). The associations of CRP with HOMA-IR and HbA1c were all null when examined using instrumental variables analysis, with genetic variants as the instrument for serum CRP. Instrumental variables estimates differed from the directly observed associations (p=0.007-0.11). Pooled analysis of CRP haplotypes and diabetes in Whitehall II and Northwick Park Heart Study II produced null findings (p=0.25-0.88). Analyses based on the Wellcome Trust Case Control Consortium (1,923 diabetes cases, 2,932 controls) using three SNPs in tight linkage disequilibrium with our tagging SNPs also demonstrated null associations. Conclusions Observed associations between serum CRP and insulin resistance, glycemia, and diabetes are likely to be noncausal. Inflammation may play a causal role via upstream effectors rather than the downstream marker CRP.
引用
收藏
页码:1278 / 1286
页数:9
相关论文
共 52 条
[1]   The relation of markers of inflammation to the development of glucose disorders in the elderly - The cardiovascular health study [J].
Barzilay, JI ;
Abraham, L ;
Heckbert, SR ;
Cushman, M ;
Kuller, LH ;
Resnick, HE ;
Tracy, RP .
DIABETES, 2001, 50 (10) :2384-2389
[2]   Effects of etanercept in patients with the metabolic syndrome [J].
Bernstein, LE ;
Berry, J ;
Kim, S ;
Canavan, B ;
Grinspoon, SK .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (08) :902-908
[3]   Human CRP gene polymorphism influences CRP levels - Implications for the prediction and pathogenesis of coronary heart disease [J].
Brull, DJ ;
Serrano, N ;
Zito, F ;
Jones, L ;
Montgomery, HE ;
Rumley, A ;
Sharma, P ;
Lowe, GDO ;
World, MJ ;
Humphries, SE ;
Hingorani, AD .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (11) :2063-2069
[4]   Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study [J].
Brunner, EJ ;
Marmot, MG ;
Nanchahal, K ;
Shipley, MJ ;
Stansfeld, SA ;
Juneja, M ;
Alberti, KGMM .
DIABETOLOGIA, 1997, 40 (11) :1341-1349
[5]   Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls [J].
Burton, Paul R. ;
Clayton, David G. ;
Cardon, Lon R. ;
Craddock, Nick ;
Deloukas, Panos ;
Duncanson, Audrey ;
Kwiatkowski, Dominic P. ;
McCarthy, Mark I. ;
Ouwehand, Willem H. ;
Samani, Nilesh J. ;
Todd, John A. ;
Donnelly, Peter ;
Barrett, Jeffrey C. ;
Davison, Dan ;
Easton, Doug ;
Evans, David ;
Leung, Hin-Tak ;
Marchini, Jonathan L. ;
Morris, Andrew P. ;
Spencer, Chris C. A. ;
Tobin, Martin D. ;
Attwood, Antony P. ;
Boorman, James P. ;
Cant, Barbara ;
Everson, Ursula ;
Hussey, Judith M. ;
Jolley, Jennifer D. ;
Knight, Alexandra S. ;
Koch, Kerstin ;
Meech, Elizabeth ;
Nutland, Sarah ;
Prowse, Christopher V. ;
Stevens, Helen E. ;
Taylor, Niall C. ;
Walters, Graham R. ;
Walker, Neil M. ;
Watkins, Nicholas A. ;
Winzer, Thilo ;
Jones, Richard W. ;
McArdle, Wendy L. ;
Ring, Susan M. ;
Strachan, David P. ;
Pembrey, Marcus ;
Breen, Gerome ;
St Clair, David ;
Caesar, Sian ;
Gordon-Smith, Katherine ;
Jones, Lisa ;
Fraser, Christine ;
Green, Elain K. .
NATURE, 2007, 447 (7145) :661-678
[6]   Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels [J].
Carlson, CS ;
Aldred, SF ;
Lee, PK ;
Tracy, RP ;
Schwartz, SM ;
Rieder, M ;
Liu, KA ;
Williams, OD ;
Iribarren, C ;
Lewis, EC ;
Fornage, M ;
Boerwinkle, E ;
Gross, M ;
Jaquish, C ;
Nickerson, DA ;
Myers, RM ;
Siscovick, DS ;
Reiner, AP .
AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 77 (01) :64-77
[7]   Insight into the nature of the CRP-coronary event association using Mendelian randomization [J].
Casas, Juan P. ;
Shah, Tina ;
Cooper, Jackie ;
Hawe, Emma ;
McMahon, Alex D. ;
Gaffney, Dairena ;
Packard, Christopher J. ;
O'Reilly, Denis S. ;
Juhan-Vague, Irene ;
Yudkin, John S. ;
Tremoli, Elena ;
Margaglione, Maurizio ;
Di Minno, Giovanni ;
Hamsten, Anders ;
Kooistra, Teake ;
Stephens, Jeffrey W. ;
Hurel, Steven J. ;
Livingstone, Shona ;
Colhoun, Helen M. ;
Miller, George J. ;
Bautista, Leonelo E. ;
Meade, Tom ;
Sattar, Naveed ;
Humphries, Steve E. ;
Hingorani, Aroon D. .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2006, 35 (04) :922-931
[8]   Sequence variations in PCSK9, low LDL, and protection against coronary heart disease [J].
Cohen, JC ;
Boerwinkle, E ;
Mosley, TH ;
Hobbs, HH .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (12) :1264-1272
[9]   Genetic variation, C-reactive protein levels, and incidence of diabetes [J].
Dehghan, Abbas ;
Kardys, Isabella ;
de Maat, Moniek P. M. ;
Uitterlinden, Andre G. ;
Sijbrands, Eric J. G. ;
Bootsma, Aart H. ;
Stijnen, Theo ;
Hofman, Albert ;
Schram, Miranda T. ;
Witteman, Jacqueline C. M. .
DIABETES, 2007, 56 (03) :872-878
[10]   Complement C3 is a risk factor for the development of diabetes -: A population-based cohort study [J].
Engström, G ;
Hedblad, B ;
Eriksson, KF ;
Janzon, L ;
Lindgärde, F .
DIABETES, 2005, 54 (02) :570-575